Published in J Antimicrob Chemother on September 01, 2000
Microbial adhesion in flow displacement systems. Clin Microbiol Rev (2006) 1.66
Comparison of various surgical methods in the treatment of implant-related infection. Int Orthop (2009) 1.32
Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts. Int J Med Sci (2009) 1.15
Decal bone matrix as a local antibiotic delivery vehicle in a MRSA-infected bone model: An experimental study. Indian J Orthop (2010) 1.05
Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci (2009) 0.98
Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats. BMC Musculoskelet Disord (2012) 0.90
Antibiotic-impregnated bone grafts in orthopaedic and trauma surgery: a systematic review of the literature. Int J Biomater (2012) 0.81
Impregnation of bone chips with antibiotics and storage of antibiotics at different temperatures: an in vitro study. BMC Musculoskelet Disord (2010) 0.81
Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro. Antimicrob Agents Chemother (2012) 0.79
Pharmacokinetic properties and systemic safety of vancomycin-impregnated cancellous bone grafts in the treatment of spondylodiscitis. Biomed Res Int (2013) 0.78
In vitro antimicrobial activity of vancomycin-eluting bioresorbable β-TCP-polylactic acid nanocomposite material for load-bearing bone repair. J Mater Sci Mater Med (2012) 0.77
A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model. PLoS One (2015) 0.76
Treatment of chronic orthopaedic infection. EFORT Open Rev (2017) 0.75
Lyophilized allogeneic bone tissue as an antibiotic carrier. Cell Tissue Bank (2016) 0.75
Allograft Bone as Antibiotic Carrier. J Bone Jt Infect (2017) 0.75
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 7.17
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Posterior parietal association cortex of the monkey: command functions for operations within extrapersonal space. J Neurophysiol (1975) 4.46
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
[Deep-freeze preservation of fungi in liquid nitrogen as a basis for standardized inocula]. Mykosen (1978) 3.06
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
In vitro activity of naftifine, a new antifungal agent. Antimicrob Agents Chemother (1981) 2.38
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative. Antimicrob Agents Chemother (1975) 2.15
Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med (1990) 2.08
Myosin conformational states determined by single fluorophore polarization. Proc Natl Acad Sci U S A (1998) 2.07
In vivo antimycotic activity of naftifine. Antimicrob Agents Chemother (1981) 2.06
Amino-acid sequence of equine renal metallothionein-1B. Proc Natl Acad Sci U S A (1976) 1.99
Why multilayer graphene on 4H-SiC(0001[over ]) behaves like a single sheet of graphene. Phys Rev Lett (2008) 1.92
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol (1992) 1.75
Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr (2000) 1.74
Scalable templated growth of graphene nanoribbons on SiC. Nat Nanotechnol (2010) 1.66
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I. Cell (1997) 1.61
[Specific interference with development and plastid enzyme formation in higher plants by elevated growth temperature]. Z Naturforsch B (1969) 1.60
Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol (1990) 1.49
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Kinetics of folding of leucine zipper domains. Biochemistry (1995) 1.47
Functional mapping in the human brain using high magnetic fields. Philos Trans R Soc Lond B Biol Sci (1999) 1.47
The SCARF osteotomy for the correction of hallux valgus deformities. Foot Ankle Int (2002) 1.45
Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther (1995) 1.44
Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients. Diabetes Care (1998) 1.43
Rapid susceptibility testing of fungi by flow cytometry using vital staining. J Clin Microbiol (1997) 1.42
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med (2001) 1.42
Does the use of low-level laser influence wound healing in chronic venous leg ulcers? J Wound Care (2005) 1.41
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting. Transplantation (2001) 1.39
Dialysis staff influence patients in formulating their advance directives. Am J Kidney Dis (1995) 1.39
Current status of whole-body counting as a means to detect and quantify previous exposures to radioactive materials. Whole-body Counting Working Group. Health Phys (1991) 1.39
Approaching the dirac point in high-mobility multilayer epitaxial graphene. Phys Rev Lett (2008) 1.35
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int (2010) 1.34
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol (1989) 1.21
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer (2004) 1.21
The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood (1996) 1.20
Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother (2000) 1.19
Electronic structure of epitaxial graphene layers on SiC: effect of the substrate. Phys Rev Lett (2007) 1.16
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2003) 1.16
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob Agents Chemother (1999) 1.15
Decreased formation of aqueous humour in insulin-dependent diabetic patients. Br J Ophthalmol (1989) 1.15
Selective killing of T lymphocytes by phototoxic liposomes. Proc Natl Acad Sci U S A (1987) 1.13
Impact of plasma protein binding on antimicrobial activity using time-killing curves. J Antimicrob Chemother (2004) 1.13
Concentrations of various antibiotics in serum and fluids accumulated in diffusion chambers implanted in various sites in rabbits. Antimicrob Agents Chemother (1980) 1.11
Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis (2001) 1.11
Twinning following oral contraceptive discontinuation. Int J Epidemiol (1981) 1.10
Social disability and psychiatric morbidity in sickle cell anemia and diabetes patients. Psychosomatics (1982) 1.09
Dynamic structure of metallothionein. FEBS Lett (1984) 1.08
Carrier relaxation in epitaxial graphene photoexcited near the Dirac point. Phys Rev Lett (2011) 1.07
Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate. Prostate (1998) 1.06
Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM. Diabetes Care (1993) 1.06
Treatment of Candida albicans fungaemia with fluconazole. J Infect (1993) 1.05
Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother (2003) 1.03
Spectroscopic, calorimetric, and kinetic demonstration of conformational adaptation in peptide-antibody recognition. Biochemistry (1995) 1.03
In vitro antimicrobial activity of the novel polymeric guanidine Akacid plus. J Hosp Infect (2006) 1.03
The role of Epstein-Barr virus in neoplastic transformation. Oncology (2001) 1.02
The measurement of premenstrual mood symptoms. J Affect Disord (1999) 1.02
Landau level spectroscopy of ultrathin graphite layers. Phys Rev Lett (2006) 1.00
Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project. Eur J Cancer (2006) 0.99
A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother (2000) 0.99
[Maternal-fetal Haemophilus influenzae infections]. Presse Med (1987) 0.99
Identification of the sensory/motor area and pathologic regions using ECoG coherence. Electroencephalogr Clin Neurophysiol (1998) 0.99
A survey of medical image registration on graphics hardware. Comput Methods Programs Biomed (2010) 0.97
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
Port-A-Cath infections in children with cancer. Eur J Cancer (2004) 0.96
[Dosimetric evaluation of conformal radiotherapy: conformity factor]. Cancer Radiother (2000) 0.96
A simple micro agar diffusion method for the determination of antibiotic concentrations in blood and other body fluids. Zentralbl Bakteriol Orig A (1978) 0.96
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology. Eur J Cancer (1997) 0.95
Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer (1994) 0.95
Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA (1993) 0.95
Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics. J Med Chem (1986) 0.95
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol (2000) 0.95
The amino acid sequence of equine metallothioneins. Experientia Suppl (1979) 0.95
Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin Exp Immunol (1996) 0.93
Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology (2009) 0.93
Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant (1992) 0.93
[Doppler examination of the umbilical arteries. Its role in the surveillance of pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1987) 0.93
Aroma compound production in cheese curd by coculturing with selected yeast and bacteria. J Dairy Sci (2001) 0.93
Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Antimicrob Agents Chemother (2011) 0.92
Time-resolved fMRI of mental rotation. Neuroreport (1997) 0.92
Endothelial cell compatibility of clarithromycin for intravenous use. Clin Biochem (1998) 0.92
Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care (1999) 0.92
[Nutritional fetal rickets. A case report]. J Gynecol Obstet Biol Reprod (Paris) (1997) 0.91
Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. Eur J Clin Microbiol Infect Dis (2002) 0.91
Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8. J Exp Med (1978) 0.91